The Molecular-Based Diagnostic Approach on Thalassemia Patient


  • Bagus Pratama
  • Intanri Kurniati



Genetic examination, molecular diagnosis, thalassemia


Thalassemia is a red blood disorder which is one of the causes of death and illness in Indonesia. This disease occurs due to genetic disorder that affect the inability of a person to synthesize globin chains. A globin chain is one of the constituents of hemoglobin so that abnormality of composition of hemoglobin will cause abnormality of elasticity and lysis of the erythrocytes. This disorder has various clinical manifestations ranging from anemia, pale, fatigue, pain, abnormalities in the bone (thalassemic facie) to jaundice and hepatosplenomegaly. Generally, the diagnosis of thalassemia uses a complete blood count including calculating the number of erythrocytes, hemoglobin levels, hematocrit levels, MCV and MCH, blood smear examination and hemoglobin electrophoresis. The genetic examination on molecular-based diagnostic approach is an examination to get a result of changes in gene sequences or genetic mutations that will affect the difference of clinical manifestation and severity of thalassemia patients. Molecular diagnosis can be made in an effort to improve the effective management and the quality of life of patients.


Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med. 2012;2(9).

Weatherall DJ. The Evolving Spectrum of the Epidemiology of Thalassemia. Hematol Oncol Clin North Am. 2018;32(2):165–75.

Liansyah, Tita Menawati; Herdata HN, Data. Aspek Klinis dan Tatalaksana Talasemia pada Anak. Banda Aceh: J.Ked. N.Med. Vol.1 No.1; 2018.

Teti A, Teitelbaum SL. Congenital disorders of bone and blood. Bone. 2019;119(2017):71–81.

Weatherall DJ. The thalassaemias. BMJ 1997; 314: 1675-8.

Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–67.

Muncie HL, Campbell JS. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4).

Cappellini MD, Cohen A, Eleftheriou A, et al. Guidelines for the clinical management of thalassaemia. 2nd revision edition. Nicosia (Cyprus): Thalassaemia International Federation; 2008

Giordano PC. Strategies for basic laboratory diagnostics of the hemoglobinopathies in multi-ethnic societies: Interpretation of results and pitfalls. Int J Lab Hematol. 2013;35(5):465–79.

Brancaleoni V, Di Pierro E, Motta I, Cappellini MD. Laboratory diagnosis of thalassemia. Int J Lab Hematol. 2016;38:32–40.

Rund D. Thalassemia 2016: Modern medicine battles an ancient disease. Am J Hematol. 2016;91(1):15–21.

Welch J. Diagnosis and management of thalassaemia. Paediatr Child Heal (United Kingdom). 2015;25(8):360–7.

Martin A, Thompson AA. Thalassemias. Pediatric of North America. 2013; 60: 1383-1391

Danjou F, Francavilla M, Anni F, Satta S, Demartis FR, Perseu L, et al. A genetic score for the prediction of beta-thalassemia severity. Haematologica. 2015;100(4):452–7.

Sarnaik SA. Thalassemia and related hemoglobinopathies. Indian J Pediatr. 2005; 72:319

Fibach E, Rachmilewitz EA. Pathophysiology and treatment of patients with beta-thalassemia – an update [version 1; referees: 2 approved] F1000Research 2017, (F1000 Faculty Rev):2156

Fibach E, Dana M. Oxidative Stress in β-Thalassemia. Mol Diagnosis Ther. 2019;23(2):245–61.

Butthep P, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S. Elevated erythropoietin and cytokines levels are related to impaired reticulocyte maturation in thalassemic patients. Blood Cells, Mol Dis. 2015;54(2):170–6.

Gupta R, Musallam KM, Taher AT, Rivella S. Ineffective erythropoiesis: anemia and iron overload. Hematol Oncol Clin North Am. 2018;32(2):213–21.

Oikonomidou PR, Rivella S. What can we learn from ineffective erythropoiesis in thalassemia? Blood Rev. 2018;32(2):130–43.

Taher AT, Saliba AN. Iron overload in thalassemia: Different organs at different rates. Hematology. 2017;2017(1):265–71.

Fibach E, Rachmilewitz EA. Iron overload in hematological disorders. Press Med. 2017; 46: e296-e305

Piel FB, Weatherall DJ. The α-Thalassemias. N Engl J Med. 2014;371(20):1908–16.

Mettananda S, Higgs DR. Molecular Basis and Genetic Modifiers of Thalassemia. Hematol Oncol Clin North Am. 2018;32(2):177–91.

Thein SL. The molecular basis of β-thalassemia. Cold Spring Harb Perspect Med. 2013;3(5).

Sabath DE. Molecular diagnosis of thalassemias and hemoglobinopathies: An ACLPS critical review. Am J Clin Pathol. 2017;148(1):6–15.

Viprakasit V, Ekwattanakit S. Clinical Classification, Screening and Diagnosis for Thalassemia. Hematol Oncol Clin North Am. 2018;32(2):193–211.

Shang X, Xu X. Update in the genetics of thalassemia: What clinicians need to know. Best Pract Res Clin Obstet Gynaecol. 2017;39:3–15.

Basha B, Mularo F, Cook JR. Design, Validation, and Clinical Implementation of a Gap-Polymerase Chain Reaction Method for α-Thalassemia Genotyping Using Capillary Electrophoresis. Hemoglobin. 2017;41(2):124–30.

Yang Y, Li DZ. Detection of uncommon deletions in alpha-thalassemia using the PCR-reverse dot-blot method for prenatal diagnosis of nondeletional hemoglobin H disease. Acta Haematol. 2010;124(1):9–12.

Xue Y, Ankala A, Wilcox WR, Hegde MR. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: Single-gene, gene panel, or exome/genome sequencing. Genet Med. 2015;17(6):444–51.

Risoluti R, Materazzi S, Sorrentino F, Bozzi C, Caprari P. Update on thalassemia diagnosis: New insights and methods. Talanta. 2018;183:216–22.

Voelkerding K V., Dames SA, Durtschi JD. Next-generation sequencing:from basic research to diagnostics. Clin Chem. 2009;55(4):641–58.

Levy SE, Myers RM. Advancements in Next-Generation Sequencing. Annu Rev Genomics Hum Genet. 2016;17(1):95–115.

Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, et al. Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet. 2016;24(1):2–5.

Clark BE, Shooter C, Smith F, Brawand D, Thein SL. Next-generation sequencing as a tool for breakpoint analysis in rearrangements of the globin gene clusters. Int J Lab Hematol. 2017;39(March):111–20.

Harteveld, CL. Diagnosis of haemoglobinopathies: New scientific advances. Thalassemia Reports, 8(1).

Taher AT, Musallam KM, Karimi M, et al. Overview on practices in thalassemia in- termedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 2010;115(10):1886–92



How to Cite

Bagus Pratama, & Intanri Kurniati. (2019). The Molecular-Based Diagnostic Approach on Thalassemia Patient. Medical Profession Journal of Lampung, 9(2), 339-345.